RIGL Rigel Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 4, 2026
$47,15
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$24,9552 haftanın en düşüğü
$52,2452 haftanın en yükseği
Piyasa Değeri
$863M
P/E (TTM)
2.8
Hisse Başına Kâr (TTM)
$16.89
Gelir (TTM)
$277M
rozetleriniz
52 Haftlık Aralık
$25–$52
Analist Derecelendirmesi
STRONG BUY
Fiyat Hedefi
$63
P/E
2.8
ROE
126.9%
Net Kâr Marjı
116.3%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
RIGL Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$47.15
Piyasa Değeri
$863M
P/E (TTM)
2.8
Hisse Başına Kâr (TTM)
$16.89
Gelir (TTM)
$277M
ROE (TTM)
126.9%
52 Haftlık Aralık
$25–$52
RIGL Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 27 Haziran 2024 | 1-for-10 | Ters |
| 25 Haziran 2003 | 1-for-9 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$294M2016-12-31 → 2025-12-31
Hisse Başına Kâr$19.482019-12-31 → 2025-12-31
Serbest Nakit Akışı·2016-12-31 → 2022-12-31
Net kar marjı116.3%2018-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | RIGL | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | 2.85Y ort. ≈-47.2 | ≈-47.2 | · | · | |
| P/S (F/S) | 2.95Y ort. ≈15.6 | ≈15.6 | 12.6 | Düşük değerli | |
| P/B (F/D) | 2.25Y ort. ≈-7.4 | ≈-7.4 | 4.6 | Düşük değerli | |
| Price / Cash Flow (Fiyat / Nakit Akışı) | 11.45Y ort. ≈63.4 | ≈63.4 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 2.4 | · | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | RIGL | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | 31.5%5Y ort. ≈-3.2% | ≈-3.2% | -180.0% | En üst düzey | |
| FAVÖK Marjı (TTM) | 32.4%5Y ort. ≈-2.2% | ≈-2.2% | -180.0% | En üst düzey | |
| Vergi Öncesi Kar Marjı (TTM) | 30.9%5Y ort. ≈-6.0% | ≈-6.0% | -170.5% | En üst düzey | |
| Net Kâr Marjı (TTM) | 116.3%5Y ort. ≈10.5% | ≈10.5% | -170.6% | En üst düzey | |
| ROA (TTM) | 88.5%5Y ort. ≈9.8% | ≈9.8% | -39.1% | En üst düzey | |
| ROE (TTM) | 126.9%5Y ort. ≈47.1% | ≈47.1% | -50.7% | En üst düzey | |
| ROIC | 96.5%5Y ort. ≈251.5% | ≈251.5% | -59.1% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | RIGL | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 1.95Y ort. ≈2.1 | ≈2.1 | 11.7 | Düşük likidite | |
| Cari Oran (MRQ) | 1.65Y ort. ≈1.9 | ≈1.9 | 4.9 | Ortalamanın altında |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | RIGL | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 64.1%5Y ort. ≈26.5% | ≈26.5% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 34.8%5Y ort. ≈14.5% | ≈14.5% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 22.1% | · | · | · | |
| EPS YoY (EPS YB) | 1867.7% | · | · | · | |
| Net Income YoY (Net Gelir Yıllık Bazda) | 1999.1% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | RIGL | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.95Y ort. ≈1.0 | ≈1.0 | 0.5 | En üst düzey | |
| Inventory Turnover (Stok Devir Hızı) | 2.25Y ort. ≈1.4 | ≈1.4 | · | · | |
| Receivables Turnover (Alacak Devir Hızı) | 6.35Y ort. ≈5.7 | ≈5.7 | · | · | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$1.7M | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
111.8%
Sonraki Rapor
Kas 02, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 3, 2026 | $0.88 | $0.63 | 39.2% |
| 31 Mart 2026 | $0.44 | $0.78 | -43.2% | |
| 31 Aralık 2025 | $1.15 | $1.27 | -9.6% | |
| 30 Eylül 2025 | $1.46 | $0.87 | 67.5% | |
| 30 Haziran 2025 | $3.28 | $2.63 | 24.6% | |
| 31 Mart 2025 | $0.63 | $0.09 | 592.3% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $294M | $179M | $117M | $120M | $149M | $109M | $59M | $45M | $4M | $20M | |
| Cost of Revenue | $20M | $19M | $7M | $2M | $1M | $895.0K | $906.0K | $287.0K | · | · | |
| R&D Expense | $33M | $23M | $25M | · | · | · | · | · | · | · | |
| SG&A Expense | $116M | $113M | $106M | $112M | $92M | $77M | $75M | $70M | $38M | $21M | |
| Operating Expenses | $169M | $155M | $137M | $176M | $162M | $138M | $128M | $117M | $84M | $90M | |
| Operating Income | $125M | $24M | $-20M | $-56M | $-12M | $-29M | $-69M | $-73M | $-80M | $-70M | |
| Interest Expense | · | $8M | $7M | $4M | $5M | $1M | $335.0K | · | · | · | |
| Interest Income | $4M | $2M | $2M | $684.0K | $47.0K | $582.0K | $3M | $2M | $892.0K | $437.0K | |
| Pretax Income | $122M | $18M | $-25M | $-59M | $-17M | $-30M | $-67M | · | · | · | |
| Income Tax | $-245M | $881.0K | $0 | · | $605.0K | · | · | $0 | $0 | $0 | |
| Net Income | $367M | $17M | $-25M | $-59M | $-18M | $-30M | $-67M | $-70M | $-78M | $-69M | |
| EPS (Basic) | $20.40 | $0.99 | $-1.44 | $-3.44 | $-0.11 | $-0.18 | $-0.40 | · | · | · | |
| EPS (Diluted) | $19.48 | $0.99 | $-1.44 | $-3.44 | $-0.11 | $-0.18 | $-0.40 | · | · | · | |
| Shares (Basic) | 17,987,000 | 17,579,000 | 17,401,000 | 17,049,000 | 170,492,000 | 168,754,000 | 167,400,000 | · | · | · | |
| Shares (Diluted) | 18,840,000 | 17,687,000 | 17,401,000 | 17,049,000 | 170,492,000 | 168,754,000 | 167,400,000 | · | · | · | |
| EBITDA | $128M | $26M | $-19M | $-55M | $-11M | $-28M | $-68M | $-72M | · | $-69M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $57M | $33M | $24M | $19M | $30M | $23M | $76M | $38M | $18M | |
| Short-term Investments | $114M | $21M | $24M | $34M | $106M | $27M | $76M | $52M | $77M | $57M | |
| Receivables | $52M | $42M | $31M | $40M | $15M | $16M | $10M | $4M | $0 | $0 | |
| Inventory | $12M | $6M | $6M | $9M | $7M | $2M | $1M | $894.0K | · | · | |
| Prepaid Expense | $22M | $10M | $6M | $8M | $7M | $14M | $9M | $3M | $2M | $1M | |
| Other Current Assets | $5M | $5M | · | · | · | · | · | · | · | · | |
| Current Assets | $240M | $135M | $99M | $116M | $154M | $89M | $119M | $137M | $117M | $76M | |
| PP&E (Net) | $30.0K | $92.0K | $165.0K | $857.0K | $2M | $3M | $2M | $1M | $875.0K | $1M | |
| PP&E (Gross) | $347.0K | $353.0K | $2M | $12M | $17M | $16M | $15M | $14M | $13M | $20M | |
| Accum. Depreciation | $317.0K | $261.0K | $2M | $11M | $15M | $14M | $13M | $13M | $12M | $19M | |
| Intangibles | $25M | $27M | $14M | $15M | · | · | · | · | · | · | |
| Other Non-current Assets | $2M | $2M | $3M | $640.0K | $974.0K | $824.0K | $696.0K | $735.0K | $803.0K | $764.0K | |
| Total Assets | $514M | $164M | $117M | $134M | $167M | $110M | $148M | $139M | $119M | $78M | |
| Accounts Payable | $7M | $3M | $7M | $23M | $4M | $4M | $4M | $6M | $3M | $6M | |
| Accrued Liabilities | · | · | · | · | $4M | $4M | $3M | · | · | · | |
| Current Liabilities | $99M | $63M | $53M | $65M | $64M | $41M | $58M | $28M | $18M | $23M | |
| Capital Leases | $395.0K | $0 | $285.0K | $972.0K | $759.0K | $11M | $19M | · | · | · | |
| Other Non-current Liabilities | $0 | $40M | $40M | $42M | $53M | $5M | $5M | · | $38.0K | $2.0K | |
| Total Liabilities | $122M | $161M | $146M | $148M | $137M | · | · | · | · | · | |
| Long-term Debt | $52M | $60M | $60M | $40M | $20M | $20M | $10M | · | · | · | |
| Common Stock | $18.0K | $18.0K | $17.0K | $174.0K | $172.0K | $169.0K | $168.0K | $167.0K | $147.0K | $100.0K | |
| Retained Earnings | $-1.02B | $-1.39B | $-1.41B | $-1.38B | $-1.32B | $-1.31B | $-1.28B | $-1.21B | $-1.14B | $-1.06B | |
| AOCI | $181.0K | $10.0K | $8.0K | $-153.0K | $-102.0K | $-4.0K | $23.0K | $-24.0K | $-82.0K | $-18.0K | |
| Stockholders' Equity | $391M | $3M | $-29M | $-14M | $30M | $34M | $54M | $110M | $101M | $55M | |
| Liabilities + Equity | $514M | $164M | $117M | $134M | $167M | $110M | $148M | $139M | $119M | $78M | |
| Shares Outstanding | 18,310,934 | 17,710,216 | 17,482,513 | 173,398,645 | 171,602,226 | 169,316,782 | 167,987,850 | 167,171,505 | 146,814,906 | 99,269,418 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $1M | $998.0K | $1M | $706.0K | $683.0K | $594.0K | $465.0K | $941.0K | |
| Stock-based Comp | $13M | $12M | $9M | $12M | $9M | $7M | $9M | $8M | $6M | $7M | |
| Deferred Tax | $-246M | $0 | $0 | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $2M | $2M | $1M | $100.0K | · | · | · | · | · | · | |
| Restructuring | · | · | · | $1M | $4M | · | · | · | · | $6M | |
| Other Non-cash | $-61M | $-635.0K | $9M | $-29M | $13M | $-30M | $16M | $3M | · | · | |
| Operating Cash Flow | $76M | $31M | $-6M | $-74M | $6M | $-52M | $-42M | $-59M | $-78M | $-76M | |
| CapEx | · | · | · | $450.0K | $627.0K | $1M | $1M | $1M | $164.0K | $804.0K | |
| Investing Cash Flow | $-92M | $4M | $-4M | $73M | $-80M | $47M | $-24M | $25M | $-19M | $25M | |
| Stock Issued | · | · | · | · | · | · | · | $67M | $114M | $24M | |
| Net Stock Activity | · | · | · | · | · | · | · | $67M | · | $30M | |
| Financing Cash Flow | $601.0K | $-12M | $18M | $7M | $63M | $13M | $11M | $72M | $118M | $25M | |
| Net Change in Cash | · | · | · | · | · | · | · | $38M | $21M | $-26M | |
| Taxes Paid | $1M | $331.0K | $81.0K | · | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | $-74M | $5M | $-53M | $-43M | $-60M | · | $-77M | |
| Levered FCF | · | · | · | · | $221.1K | · | · | · | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 42.6% | 13.5% | -17.5% | -46.2% | -8.4% | -26.7% | -116.5% | -163.3% | · | · | |
| Net Margin | 124.7% | 9.8% | -21.5% | -48.7% | -12.0% | -27.4% | -112.8% | -158.3% | · | · | |
| Pretax Margin | 41.4% | 10.2% | -21.5% | -48.7% | -11.6% | · | · | · | · | · | |
| EBITDA Margin | 43.5% | 14.7% | -16.5% | -45.4% | -7.6% | -26.0% | -115.4% | -162.0% | · | · | |
| ROA | 108.3% | 12.4% | -20.0% | -38.8% | -12.9% | -23.1% | -46.7% | -54.6% | · | · | |
| ROE | 155.1% | -308.2% | 83.0% | 350.2% | -44.8% | -70.0% | -109.0% | -66.1% | · | · | |
| ROIC | 96.5% | 700.5% | · | · | -42.6% | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | 2.1 | 1.9 | 1.8 | 2.4 | 2.2 | 2.0 | 4.9 | · | 3.4 | |
| Quick Ratio | 2.1 | 1.9 | 1.6 | 1.5 | 2.2 | 1.8 | 1.9 | 4.8 | · | 3.3 | |
| Interest Coverage | · | 3.1 | -3.0 | -15.0 | -2.6 | -21.4 | -206.2 | · | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 1.3 | 0.9 | 0.8 | 1.1 | 0.8 | 0.4 | 0.3 | · | · | |
| Inventory Turnover | 2.2 | 3.2 | 1.0 | 0.2 | 0.3 | 0.6 | 0.8 | 0.6 | · | · | |
| Receivables Turnover | 6.3 | 5.0 | 3.3 | 4.3 | 9.5 | 8.3 | 8.4 | 21.8 | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $21.38 | $0.19 | $-0.16 | $-0.08 | $0.18 | $0.20 | $0.32 | $0.66 | · | $0.55 | |
| Revenue / Share | $15.62 | $10.14 | $0.67 | $0.70 | $0.88 | · | · | · | · | · | |
| Cash Flow / Share | $4.02 | $1.78 | $-0.03 | $-0.43 | $0.03 | · | · | · | · | · | |
| Cash / Share | $2.22 | $3.20 | $0.19 | $0.14 | $0.11 | $0.18 | $0.13 | $0.46 | · | $0.18 | |
| EPS (TTM) | $19.48 | $0.99 | $-1.44 | $-3.44 | $-0.11 | $-0.18 | $-0.40 | · | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 64.1% | 53.4% | -2.8% | -19.4% | 37.4% | · | · | · | · | · | |
| Revenue CAGR 3Y | 34.8% | 6.3% | 2.5% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 22.1% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 1867.7% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 1999.1% | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $294M | $179M | $117M | $120M | $149M | $109M | $59M | $45M | $4M | $20M | |
| Net Income TTM | $367M | $17M | $-25M | $-59M | $-18M | $-30M | $-67M | $-70M | $-78M | $-69M | |
| Market Cap | $784M | $298M | $2.53B | $2.60B | $4.55B | $5.93B | $3.59B | $3.84B | · | $2.36B | |
| P/E | 2.2 | 17.0 | -10.1 | -4.4 | -240.9 | -194.4 | -53.5 | · | · | · | |
| P/S | 2.7 | 1.7 | 21.7 | 21.6 | 30.5 | 54.6 | 60.6 | 86.4 | · | 115.9 | |
| P/B | 2.0 | 90.6 | -88.5 | -191.0 | 149.7 | 174.2 | 66.8 | 35.0 | · | 42.9 | |
| P / Tangible Book | 2.1 | · | · | · | 149.7 | 174.2 | · | · | · | · | |
| P / Cash Flow | 10.4 | 9.5 | -441.4 | -35.3 | 773.6 | -113.6 | -86.6 | -65.4 | · | -31.1 | |
| P / FCF | · | · | · | -35.0 | 866.0 | -110.9 | -83.7 | -64.2 | · | -30.8 | |
| Earnings Yield | 45.5% | 5.9% | -9.9% | -22.9% | -0.42% | -0.51% | -1.9% | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $79M | $59M | $70M | $69M | $102M | $53M | $58M | $55M | $37M | $30M | $28M | $27M | $26M | $22M | $30M | $17M | |
| Cost of Revenue | $9M | $5M | $6M | $5M | $5M | $4M | $6M | $8M | $3M | $2M | $1M | $1M | $977.0K | $250.0K | $1M | $121.0K | |
| R&D Expense | $14M | $12M | · | · | $7M | $8M | · | · | · | · | · | · | · | · | · | · | |
| SG&A Expense | $33M | $31M | $30M | $29M | $29M | $28M | $30M | $27M | $28M | $28M | $25M | $26M | $28M | $26M | $27M | $27M | |
| Operating Expenses | $55M | $47M | $47M | $41M | $41M | $41M | $41M | $41M | $36M | $36M | $33M | $32M | $39M | $41M | $43M | $43M | |
| Operating Income | $24M | $12M | $23M | $28M | $61M | $13M | $17M | $14M | $447.0K | $-7M | $-4M | $-5M | $-13M | $-18M | $-13M | $-26M | |
| Interest Expense | · | · | · | $2M | $2M | $2M | · | $2M | $2M | $2M | $2M | $2M | $1M | $826.0K | $569.0K | $1M | |
| Interest Income | $789.0K | $1M | $1M | $1M | $753.0K | $591.0K | $522.0K | $425.0K | $552.0K | $593.0K | $672.0K | $529.0K | $393.0K | $192.0K | $42.0K | $21.0K | |
| Pretax Income | $24M | $12M | $23M | $28M | $60M | $12M | $15M | $12M | $-1M | $-8M | · | · | · | $-19M | $-13M | $-27M | |
| Income Tax | $6M | $3M | $-245M | $-280.0K | $369.0K | $65.0K | $881.0K | $0 | $0 | $0 | · | · | · | $0 | $0 | $0 | |
| Net Income | $17M | $9M | $268M | $28M | $60M | $11M | $14M | $12M | $-1M | $-8M | $-6M | $-7M | $-14M | $-19M | $-13M | $-27M | |
| EPS (Basic) | $0.93 | $0.47 | $14.88 | $1.55 | $3.33 | $0.64 | $0.81 | $0.71 | $-0.06 | $-0.47 | $-0.33 | $-0.38 | $-0.08 | $-0.11 | $-0.08 | $-0.16 | |
| EPS (Diluted) | $0.88 | $0.44 | $14.11 | $1.46 | $3.28 | $0.63 | $0.82 | $0.70 | $-0.06 | $-0.47 | $-0.33 | $-0.38 | $-0.08 | $-0.11 | $-0.08 | $-0.16 | |
| Shares (Basic) | 18,541,000 | 18,412,000 | · | 18,038,000 | 17,885,000 | 17,808,000 | · | 17,600,000 | 17,549,000 | 17,520,000 | 17,436,000 | 17,356,000 | 173,568,000 | 172,836,000 | 172,147,000 | 171,774,000 | |
| Shares (Diluted) | 19,570,000 | 19,686,000 | · | 19,156,000 | 18,162,000 | 18,169,000 | · | 17,648,000 | 17,549,000 | 17,520,000 | 17,436,000 | 17,356,000 | 173,568,000 | 172,836,000 | 172,147,000 | 171,774,000 | |
| EBITDA | $24M | $12M | · | $28M | $61M | $13M | · | $14M | $447.0K | $-7M | $-4M | $-5M | $-12M | $-18M | $-13M | $-26M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $61M | $24M | $41M | $49M | $53M | $46M | $57M | $52M | $36M | $26M | $45M | $49M | $40M | $30M | $27M | $25M | |
| Short-term Investments | $35M | $122M | $114M | $89M | $55M | $31M | $21M | $9M | $13M | $24M | $17M | $16M | $18M | $52M | $62M | $83M | |
| Receivables | $56M | $50M | $52M | $46M | $40M | $42M | $42M | $31M | $29M | $28M | $24M | $21M | $29M | $16M | $17M | $15M | |
| Inventory | $14M | $12M | $12M | $13M | $10M | $5M | $6M | $5M | $8M | $7M | $6M | $11M | $11M | $7M | $6M | $7M | |
| Prepaid Expense | $20M | $26M | $22M | $19M | $17M | $23M | $10M | $10M | $9M | $9M | $3M | $5M | $8M | $6M | $8M | $9M | |
| Other Current Assets | $5M | $7M | $5M | $6M | $5M | $6M | $5M | · | · | · | · | · | · | · | · | · | |
| Current Assets | $186M | $234M | $240M | $215M | $175M | $147M | $135M | $106M | $95M | $92M | $95M | $101M | $107M | $110M | $121M | $139M | |
| PP&E (Net) | · | · | $30.0K | $54.0K | $57.0K | $76.0K | $92.0K | $99.0K | $115.0K | $140.0K | $190.0K | $215.0K | $294.0K | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | $347.0K | · | · | · | $353.0K | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $317.0K | · | · | · | $261.0K | · | · | · | · | · | · | · | · | · | |
| Intangibles | $94M | $24M | $25M | $25M | $26M | $27M | $27M | $28M | $28M | $29M | · | · | · | · | · | · | |
| Other Non-current Assets | $3M | $2M | $2M | $1M | $4M | $2M | $2M | $5M | $5M | $4M | $5M | $541.0K | $542.0K | $484.0K | $403.0K | $464.0K | |
| Total Assets | $521M | $505M | $514M | $243M | $207M | $176M | $164M | $139M | $128M | $127M | $115M | $117M | $124M | $116M | $128M | $149M | |
| Accounts Payable | $4M | $4M | $7M | $4M | $7M | $4M | $3M | $4M | $6M | $9M | $8M | $5M | $6M | $3M | $2M | $5M | |
| Current Liabilities | $96M | $89M | $99M | $94M | $87M | $67M | $63M | $54M | $59M | $73M | $48M | $44M | $46M | $47M | $55M | $59M | |
| Capital Leases | $58.0K | $228.0K | $395.0K | $556.0K | $714.0K | $864.0K | $0 | · | · | $100.0K | $466.0K | $628.0K | $802.0K | · | · | · | |
| Other Non-current Liabilities | · | · | $0 | · | · | $40M | $40M | $40M | $40M | $40M | $39M | $41M | $42M | $49M | $47M | $53M | |
| Total Liabilities | $96M | $105M | $122M | $125M | $125M | $157M | $161M | $154M | $158M | $158M | $147M | $145M | $148M | · | · | · | |
| Long-term Debt | · | $45M | $52M | $60M | $60M | $60M | · | $60M | $60M | $60M | $60M | $60M | $60M | $40M | $30M | $30M | |
| Common Stock | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $17.0K | $17.0K | $175.0K | $175.0K | $175.0K | $174.0K | $173.0K | $173.0K | $172.0K | |
| Retained Earnings | $-997M | $-1.01B | $-1.02B | $-1.29B | $-1.32B | $-1.38B | $-1.39B | $-1.40B | $-1.42B | $-1.42B | $-1.41B | $-1.40B | $-1.40B | $-1.38B | $-1.36B | $-1.35B | |
| AOCI | $-148.0K | $-128.0K | $181.0K | $96.0K | $6.0K | $-2.0K | $10.0K | $11.0K | $-9.0K | $-5.0K | $-15.0K | $-25.0K | $-27.0K | $-286.0K | $-438.0K | $-416.0K | |
| Stockholders' Equity | $425M | $400M | $391M | $118M | $82M | $19M | $3M | $-15M | $-30M | $-32M | $-32M | $-28M | $-24M | $-20M | $-4M | $7M | |
| Liabilities + Equity | $521M | $505M | $514M | $243M | $207M | $176M | $164M | $139M | $128M | $127M | $115M | $117M | $124M | $116M | $128M | $149M | |
| Shares Outstanding | · | · | 18,310,934 | · | · | · | 17,710,216 | · | · | · | · | · | · | · | · | · |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $848.0K | $597.0K | $601.0K | $603.0K | $607.0K | $604.0K | $604.0K | $611.0K | $613.0K | $400.0K | $292.0K | $296.0K | $357.0K | $240.0K | $237.0K | $237.0K | |
| Stock-based Comp | $7M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $5M | $2M | $2M | $3M | $3M | $2M | $3M | |
| Amort. of Intangibles | · | $600.0K | $600.0K | $600.0K | $600.0K | $600.0K | $500.0K | $600.0K | $600.0K | $400.0K | $300.0K | $300.0K | $300.0K | · | · | · | |
| Other Non-cash | · | $-10M | · | · | · | $-16M | · | · | · | $-2M | · | · | $6M | · | · | $-2M | |
| Operating Cash Flow | $31M | $3M | $22M | $24M | $31M | $-893.0K | $15M | $22M | $302.0K | $-5M | $-1M | $6M | $-4M | $-13M | $-13M | $-26M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | $189.0K | $-36.0K | $224.0K | |
| Investing Cash Flow | $17M | $-8M | $-25M | $-33M | $-23M | $-11M | $-11M | $4M | $11M | $313.0K | $-1M | $3M | $777.0K | $10M | $21M | $23M | |
| Stock Repurchased | $511.0K | $4M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-4M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-12M | $-11M | $-5M | $4M | $418.0K | $484.0K | $1M | $-10M | $-752.0K | $-3M | $-869.0K | $-373.0K | $19M | $6M | $-6M | $9M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-26M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-27M |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 29.9% | 20.2% | · | 40.9% | 60.1% | 23.9% | · | 25.4% | 1.2% | -23.6% | -15.9% | -19.6% | -48.8% | -82.1% | -43.5% | -156.9% | |
| Net Margin | 22.0% | 14.7% | · | 40.2% | 58.6% | 21.5% | · | 22.5% | -2.8% | -27.9% | -20.2% | -24.6% | -51.9% | -85.0% | -45.2% | -164.0% | |
| Pretax Margin | 30.0% | 19.8% | · | 39.8% | 59.0% | 21.6% | · | · | · | · | · | · | · | -85.0% | -45.2% | -164.0% | |
| EBITDA Margin | 29.9% | 21.2% | · | 40.9% | 60.1% | 25.1% | · | 25.4% | 1.2% | -22.2% | -15.9% | -19.6% | -47.4% | -82.1% | -43.5% | -155.5% | |
| ROA | 4.8% | 2.5% | · | 14.6% | 35.6% | 7.6% | · | 9.8% | -0.84% | -6.6% | -4.9% | -5.4% | -9.9% | -12.6% | -8.2% | -15.0% | |
| ROE | 6.8% | 4.1% | · | 54.2% | 229.2% | -174.7% | · | -53.5% | 3.5% | 29.5% | 22.0% | 41.5% | 155.1% | -127.6% | -41.9% | -64.5% | |
| ROIC | 4.1% | 2.2% | · | 24.4% | 74.1% | 68.4% | · | · | · | · | · | · | · | 92.8% | 352.6% | -386.3% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 2.6 | · | 2.3 | 2.0 | 2.2 | · | 2.0 | 1.6 | 1.3 | 2.0 | 2.3 | 2.4 | 2.3 | 2.2 | 2.3 | |
| Quick Ratio | 1.6 | 2.2 | · | 1.9 | 1.7 | 1.8 | · | 1.7 | 1.3 | 1.1 | 1.8 | 1.9 | 1.9 | 2.1 | 1.9 | 2.1 | |
| Interest Coverage | · | · | · | 15.0 | 32.6 | 6.9 | · | 6.8 | 0.2 | -3.7 | -2.4 | -2.8 | -10.6 | -22.3 | -22.8 | -21.8 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.4 | 0.6 | 0.4 | · | 0.4 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.1 | |
| Inventory Turnover | 0.7 | 0.6 | · | 0.5 | 0.5 | 0.8 | · | 1.5 | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.2 | 0.0 | |
| Receivables Turnover | 1.6 | 1.3 | · | 1.8 | 3.0 | 1.5 | · | 2.0 | 1.5 | 1.0 | 1.4 | 1.4 | 1.2 | 1.5 | 1.7 | 0.2 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $4.02 | $2.99 | · | $3.63 | $5.60 | $2.94 | · | $3.13 | $2.10 | $0.17 | $0.16 | $0.15 | $0.15 | $0.13 | $0.17 | $0.10 | |
| Cash Flow / Share | · | $0.14 | · | · | · | $-0.05 | · | · | · | $-0.03 | · | · | $-0.02 | · | · | $-0.15 | |
| EPS (TTM) | $16.89 | $19.29 | · | $6.19 | $5.43 | $2.09 | · | $-0.48 | $-1.51 | $-1.83 | $-3.88 | $-3.66 | $-3.36 | $-0.48 | $-0.49 | $-0.49 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $277M | $300M | · | $282M | $268M | $203M | · | $157M | $130M | $120M | $132M | $127M | $130M | $89M | $89M | $85M | |
| Net Income TTM | $322M | $364M | · | $113M | $98M | $37M | · | $4M | $-14M | $-20M | $-24M | $-38M | $-45M | $-83M | $-85M | $-85M | |
| P/E | 2.3 | 1.4 | · | 4.6 | 3.4 | 8.6 | · | -33.7 | -5.4 | -8.1 | -2.8 | -3.5 | -3.9 | -24.6 | -23.1 | -61.0 | |
| Earnings Yield | 43.2% | 71.3% | · | 21.9% | 29.0% | 11.6% | · | -3.0% | -18.4% | -12.4% | -35.9% | -28.4% | -25.4% | -4.1% | -4.3% | -1.6% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $294M | $179M | $117M | $120M | $149M |
| Faaliyet Kâr Marjı % | 42.6% | 13.5% | -17.5% | -46.2% | -8.4% |
| Net Gelir | $367M | $17M | $-25M | $-59M | $-18M |
| Seyreltilmiş Hisse Başı Kâr | $19.48 | $0.99 | $-1.44 | $-3.44 | $-0.11 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 2.4 | 2.1 | 1.9 | 1.8 | 2.4 |
| Cari Oran | 2.1 | 1.9 | 1.6 | 1.5 | 2.2 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | · | · | · | $-74M | $5M |
Kurumsal Sahipler (13F) 168 dosya · $637.8M toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
168
Tutulan Değer
$637.8M
Yeni pozisyonlar
31
Çıkan pozisyonlar
23
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 31 (+13 önceki Ç'ye göre) | 23 (-21 önceki Ç'ye göre) | 53 (-15 önceki Ç'ye göre) | 57 (+9 önceki Ç'ye göre) | +269K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| BlackRock, Inc. | $75.885.690 | 1.939.818 | 11,90% | Hisse senetleri |
| Soleus Capital Management, L.P. | $72.117.876 | 1.843.504 | 11,31% | Hisse senetleri |
| ARMISTICE CAPITAL, LLC | $65.408.640 | 1.672.000 | 10,26% | Hisse senetleri |
| VANGUARD GROUP INC | $44.475.015 | 1.038.408 | 6,97% | Hisse senetleri |
| STATE STREET CORP | $40.684.565 | 1.039.994 | 6,38% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $30.713.386 | 785.107 | 4,82% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $29.016.008 | 741.718 | 4,55% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $21.224.126 | 542.539 | 3,33% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $18.906.353 | 483.175 | 2,96% | Hisse senetleri |
| MARSHALL WACE, LLP | $14.372.414 | 367.393 | 2,25% | Hisse senetleri |
| CM Management, LLC | $9.780.000 | 250.000 | 1,53% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $9.143.439 | 233.728 | 1,43% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $8.917.295 | 227.951 | 1,40% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $8.871.634 | 226.780 | 1,39% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $8.120.451 | 207.578 | 1,27% | Hisse senetleri |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $7.628.000 | 195.000 | 1,20% | Hisse senetleri |
| MORGAN STANLEY | $7.278.237 | 186.049 | 1,14% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $6.049.008 | 154.627 | 0,95% | Hisse senetleri |
| NORTHERN TRUST CORP | $5.726.425 | 146.381 | 0,90% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $5.705.496 | 145.846 | 0,89% | Hisse senetleri |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $5.131.644 | 131.177 | 0,80% | Hisse senetleri |
| AQR CAPITAL MANAGEMENT LLC | $4.882.214 | 124.801 | 0,77% | Hisse senetleri |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $4.858.078 | 124.184 | 0,76% | Hisse senetleri |
| Nuveen, LLC | $4.849.354 | 123.961 | 0,76% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $4.831.556 | 123.506 | 0,76% | Hisse senetleri |
| FRANKLIN RESOURCES INC | $4.825.999 | 123.364 | 0,76% | Hisse senetleri |
| UBS Group AG | $4.809.960 | 122.954 | 0,75% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $4.762.195 | 121.733 | 0,75% | Hisse senetleri |
| GLOBEFLEX CAPITAL L P | $4.407.729 | 112.672 | 0,69% | Hisse senetleri |
| CenterBook Partners LP | $4.286.574 | 109.575 | 0,67% | Hisse senetleri |
| Bank of New York Mellon Corp | $4.233.132 | 108.209 | 0,66% | Hisse senetleri |
| FMR LLC | $3.759.903 | 96.112 | 0,59% | Hisse senetleri |
| RITHOLTZ WEALTH MANAGEMENT | $3.694.884 | 94.450 | 0,58% | Hisse senetleri |
| JANUS HENDERSON GROUP PLC | $3.674.114 | 135.877 | 0,58% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $3.665.114 | 93.689 | 0,57% | Hisse senetleri |
| FIRST TRUST ADVISORS LP | $3.182.099 | 81.342 | 0,50% | Hisse senetleri |
| Empowered Funds, LLC | $3.097.678 | 79.184 | 0,49% | Hisse senetleri |
| Brandywine Global Investment Management, LLC | $3.065.343 | 71.570 | 0,48% | Hisse senetleri |
| Russell Investments Group, Ltd. | $2.973.196 | 76.002 | 0,47% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.687.544 | 68.700 | 0,42% | Alım opsiyonu |
| Squarepoint Ops LLC | $2.607.661 | 66.658 | 0,41% | Hisse senetleri |
| BURNEY CO/ | $2.181.683 | 55.769 | 0,34% | Hisse senetleri |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $2.159.424 | 55.200 | 0,34% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $2.131.727 | 54.492 | 0,33% | Hisse senetleri |
| PRINCIPAL FINANCIAL GROUP INC | $2.032.088 | 51.945 | 0,32% | Hisse senetleri |
| OMERS ADMINISTRATION Corp | $2.030.328 | 51.900 | 0,32% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $1.989.800 | 50.864 | 0,31% | Hisse senetleri |
| Woodline Partners LP | $1.956.000 | 50.000 | 0,31% | Hisse senetleri |
| Connor, Clark & Lunn Investment Management Ltd. | $1.920.636 | 49.096 | 0,30% | Hisse senetleri |
| SEGALL BRYANT & HAMILL, LLC | $1.794.747 | 45.878 | 0,28% | Hisse senetleri |
Aktivistler ve %5+ sahipler 5 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 27 Ocak 2005 | · | İlk başvuru | Pasif yatırım | SEC |
| I.R.S.Identification Nos. of above persons (entities only). FRAZIER HEALTHCARE II, L.P., I.R.S.Identification Nos. of above persons (entities only). FHM II, L.L.C., I.R.S.Identification Nos. of above persons (entities only). FRAZIER HEALTHCARE IV, L.P., I.R.S.Identification Nos. of above persons (entities only). FRAZIER AFFILIATES IV, L.P.., I.R.S.Identification Nos. of above persons (entities only). FHM IV, L.P., I.R.S.Identification Nos. of above persons (entities only). FHM IV, L.L.C., I.R.S.Identification Nos. of above persons (entities only). FRAZIER MANAGEMENT, L.L.C., I.R.S.Identification Nos. of above persons (entities only). FRAZIER & COMPANY, INC., I.R.S.Identification Nos. of above persons (entities only). ALAN D. FRAZIER | 14 Nisan 2004 | · | İlk başvuru | Pasif yatırım | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 07 Temmuz 2003 | · | İlk başvuru | Yönetim kurulu kampanyası | SEC |
| MPM BioVentures III, L.P., MPM BioVentures III-QP, L.P., MPM BioVentures III Parallel Fund, L.P., MPM BioVentures III GmbH & Co. Beteiligungs KG, MPM Asset Management Investors 2003 BVIII, LLC, MPM BioEquities Master Fund, L.P., MPM BioVentures III GP, LP, MPM BioVentures III LLC, MPM BioEquities GP, LP, MPM BioEquities GP, LLC, Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Dennis Henner, Robert Liptak, Nick Simon, III, Michael Steinmetz, Kurt von Emster, Kurt Wheeler | 07 Temmuz 2003 | · | İlk başvuru | Yönetim kurulu kampanyası | SEC |
| MPM Bio Ventures III, L.P., MPM Bio Ventures III-QP, L.P., MPM Bio Ventures III Parallel Fund, L.P., MPM Bio Ventures III GmbH & Co. Beteiligungs KG, MPM Asset Management Investors 2003 BVIII, LLC, MPM BioEquities Master Fund, L.P., MPM Bio Ventures III GP, L.P., MPM Bio Ventures III LLC, MPM BioEquities GP, L.P., MPM BioEquities GP, LLC, Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Dennis Henner, Robert Liptak, Nicholas Simon, III, Michael Steinmetz, Kurt von Emster, Kurt Wheeler | 14 Mayıs 2003 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 41 içeriden öğrenenler · 20 yöneticiler · 20 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Raul R Rodriguez | CEO, President | 01 Eylül 2026 F | 273.362 | 0 | 0 | $0 |
| James M Gower | CEO & Board Chairman | 27 Şubat 2014 A | 180.676 | 0 | 0 | $0 |
| Dean L Schorno | EVP & Chief Financial Officer | 02 Eylül 2026 M | 82.962 | 0 | 0 | $0 |
| Ryan D Maynard | EVP & CFO | 03 Kasım 2017 M | 0 | 0 | 0 | $0 |
| James H Welch | CFO, VP & Secretary | 25 Ocak 2006 A | 3.757 | 0 | 0 | $0 |
| David A Santos | EVP, Chief Commercial Officer | 01 Eylül 2026 F | 61.622 | 0 | 0 | $0 |
| Raymond J. Furey | EVP, GC, CCO & Corp Sec | 01 Eylül 2026 F | 50.559 | 0 | 0 | $0 |
| Alison L. Hannah | EVP, Chief Medical Officer | 08 Temmuz 2026 A | 35.025 | 0 | 0 | $0 |
| Lisa Rojkjaer | EVP, Chief Medical Officer | 17 Haziran 2026 A | 34.003 | 0 | 0 | $0 |
| Wolfgang Dummer | EVP & CMO | 02 Şubat 2023 S | 72.459 | 0 | 0 | $0 |
| Dolly Vance | EVP Corp. Affairs, G.C., Sect. | 14 Eylül 2022 A | 60.260 | 0 | 0 | $0 |
| Nelson Cabatuan | VP,Finance & Princ.Acctg. Off. | 14 Mayıs 2020 A | 58 | 0 | 0 | $0 |
| Eldon C. Mayer III | EVP & Chief Commercial Officer | 18 Kasım 2019 A | 215.000 | 0 | 0 | $0 |
| Joseph Lasaga | Sr.VP Bus.Dev.Alliance Mgmt. | 18 Kasım 2019 A | · | 0 | 0 | $0 |
| Esteban Masuda | Sr. VP Research | 18 Kasım 2019 S | · | 0 | 0 | $0 |
| Stacy Markel | EVP Human Resources | 20 Mart 2019 A | · | 0 | 0 | $0 |
| Anne-Marie Duliege | EVP & Chief Medical Officer | 20 Mart 2019 A | 0 | 0 | 0 | $0 |
| Donald G Payan | EVP, Pres. Discovery&Research | 30 Ağustos 2016 S | 53.031 | 0 | 0 | $0 |
| Elliot B Grossbard | EVP, CMO | 26 Ocak 2016 A | 2.000 | 0 | 0 | $0 |
| Robin D G Cooper | Sr. V.P. Pharmaceutical Scs. | 31 Ocak 2008 A | 9.000 | 0 | 0 | $0 |
| Kamil Ali-Jackson | Yönetim kurulu üyesi | 22 Haziran 2026 S | 10.125 | 0 | 2 | $-160.425 |
| Mark W Frohlich | Yönetim kurulu üyesi | 15 Mayıs 2026 A | 7.000 | 0 | 0 | $0 |
| Jane Wasman | Yönetim kurulu üyesi | 15 Mayıs 2026 A | 18.250 | 0 | 0 | $0 |
| Anthony Gregg Lapointe | Yönetim kurulu üyesi | 15 Mayıs 2026 A | 18.250 | 0 | 0 | $0 |
| MILLER MICHAEL PATRICK | Yönetim kurulu üyesi | 15 Mayıs 2026 A | 5.937 | 0 | 0 | $0 |
| Walter H Moos | Yönetim kurulu üyesi | 15 Mayıs 2026 A | 18.472 | 0 | 1 | $-145.440 |
| Brian L. Kotzin | Yönetim kurulu üyesi | 25 Mayıs 2024 A | 100.000 | 0 | 0 | $0 |
| LYONS GARY A | Yönetim kurulu üyesi | 26 Mayıs 2023 A | 75.000 | 0 | 0 | $0 |
| Keith Katkin | Yönetim kurulu üyesi | 19 Mayıs 2021 A | 25.000 | 0 | 0 | $0 |
| Bradford S Goodwin | Yönetim kurulu üyesi | 19 Mayıs 2021 A | 35.000 | 0 | 0 | $0 |
| Peter S Ringrose | Yönetim kurulu üyesi | 17 Mayıs 2018 A | · | 0 | 0 | $0 |
| SHERWIN STEPHEN A | Yönetim kurulu üyesi | 11 Mayıs 2016 A | · | 0 | 0 | $0 |
| Hollings Renton | Yönetim kurulu üyesi | 15 Mayıs 2013 A | · | 0 | 0 | $0 |
| Jean Deleage | Yönetim kurulu üyesi | 28 Mayıs 2010 A | 697 | 0 | 0 | $0 |
| Alan D Frazier | Yönetim kurulu üyesi | 07 Ağustos 2006 A | 10.905 | 0 | 0 | $0 |
| Nicholas J Simon III | Yönetim kurulu üyesi | 03 Haziran 2005 A | 0 | 0 | 0 | $0 |
| Dennis Henner | Yönetim kurulu üyesi | 05 Ocak 2005 S | 0 | 0 | 0 | $0 |
| Michael Steinmetz | 10% sahip | 02 Ağustos 2004 S | 1.833.597 | 0 | 0 | $0 |
| Nicholas Galakatos | 10% sahip | 02 Temmuz 2004 S | 1.833.597 | 0 | 0 | $0 |
| Luke Evnin | 10% sahip | 02 Temmuz 2004 S | 1.833.597 | 0 | 0 | $0 |
| ANSBERT GADICKE | 10% sahip | 02 Temmuz 2004 J | 0 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 31 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,54% | 41.313 NS | 31 Temmuz 2026 | N-PORT |
| IDNA · iShares Trust | 0,82% | 44.383 SH | 11 Eylül 2026 | Günlük |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,53% | 2.596 SH | 02 Ekim 2026 | Günlük |
| IWC · iShares Trust | 0,21% | 62.481 SH | 11 Eylül 2026 | Günlük |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,18% | 29.124 NS | 31 Temmuz 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,16% | 22.093 NS | 31 Temmuz 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,13% | 23.978 SH | 19 Ağustos 2026 | Günlük |
| CALF · Pacer Funds Trust | 0,09% | 84.790 NS | 31 Temmuz 2026 | N-PORT |
| IBB · iShares Trust | 0,06% | 136.671 SH | 11 Eylül 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,06% | 1.309 SH | 02 Ekim 2026 | Günlük |
| VFMO · VANGUARD WELLINGTON FUND | 0,05% | 27.549 SH | 19 Ağustos 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,05% | 15.998 SH | 19 Ağustos 2026 | Günlük |
| PWS · Pacer Funds Trust | 0,05% | 302 NS | 31 Temmuz 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 473.179 SH | 11 Eylül 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 12.438 SH | 02 Ekim 2026 | Günlük |
| RSSL · Global X Funds | 0,02% | 8.801 NS | 31 Temmuz 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 105.855 SH | 19 Ağustos 2026 | Günlük |
| TECB · iShares Trust | 0,02% | 1.868 SH | 11 Eylül 2026 | Günlük |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 619 SH | 02 Ekim 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 212.359 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,01% | 54.159 SH | 19 Ağustos 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,01% | 32.659 NS | 31 Temmuz 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 6.553 SH | 09 Eylül 2026 | Günlük |
| DFAC · Dimensional ETF Trust | 0,00% | 16.178 NS | 31 Temmuz 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 22.835 SH | 11 Eylül 2026 | Günlük |
| DFAU · Dimensional ETF Trust | 0,00% | 3.010 NS | 31 Temmuz 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 699 NS | 31 Temmuz 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 555.846 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.629 SH | 19 Ağustos 2026 | Günlük |
| DFUV · Dimensional ETF Trust | 0,00% | 112 NS | 31 Temmuz 2026 | N-PORT |
| IWN · iShares Trust | · | 171.420 SH | 11 Eylül 2026 | Günlük |
RIGL Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 11 analist
AL
Medyan hedef
$55.00
+16,6%
4 36,4%
Güçlü Al
4 36,4%
Al
3 27,3%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
5 analist · 2026-10-05Ortalama hedef $63.00 +33,6%
Şimdi
Mevcut fiyat $47.15
Düşük$43.00
Ortalama$63.00
Yüksek$85.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| RIGL | $784M | 2.2 | 64.1% | 124.7% | 155.1% | · |
| KURA | $913M | -3.3 | 25.2% | -413.0% | -116.2% | · |
| CRVS | $575M | -14.5 | · | · | -21.6% | · |
| GLUE | $1.03B | · | 63.5% | -31.2% | -15.4% | · |
| JBIO | $761M | -4.8 | · | · | -47.7% | · |
| SANA | $1.09B | -4.2 | · | · | -172.3% | · |
| OBX | · | · | · | · | · | · |
| ARDX | $1.42B | -22.4 | 22.1% | -15.1% | -40.2% | · |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | · |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 4, 2026